Hubei Jumpcan Pharmaceutical Co.,Ltd.’s Net Profit Rose 26.5% in 2022

Hubei Jumpcan Pharmaceutical Co.,Ltd. (湖北济川药业股份有限公司) (600566.SH) reported a net profit of 2.2 billion yuan in 2022, up 26.5% year-on-year.

Meanwhile, the company posted 9 billion yuan in revenue, up 17.9% year-on-year.

At the end of the reporting period, it had 15 billion yuan in total assets and 3.6 billion yuan in total liabilities, with a liability-to-asset ratio of 24.2%.